The Malignant Tumor as a Hybrid Biological System: A Tripartite Integration Hypothesis

The Malignant Tumor as a Hybrid Biological System: A Tripartite Integration Hypothesis Abstract Background: Advanced malignant tumors exhibit "intelligent" behaviors that conventional somatic mutation theory fails to adequately explain, including ultra-rapid parallel evolution, coordinated therapeutic resistance, and non-random metastatic patterns. Hypothesis: We propose that advanced tumors function as emergent hybrid biological systems comprising three functionally integrated layers: (1) activated Human Endogenous Retroviruses (HERVs) serving as an intercellular communication network, (2) extrachromosomal DNA (ecDNA) providing a rapidly reprogrammable genetic memory, and (3) tumor-associated microbiome acting as environmental sensors and metabolic modulators. The synergistic interaction among these components generates adaptive capabilities exceeding those of any individual element. Evidence: Published data demonstrate that HERVs are activated in 70-90% of advanced cancers and can transfer information via extracellular vesicles. ecDNA is present in 30-40% of advanced tumors and enables genomic reorganization within days. Intratumoral bacteria exist in most solid tumors and influence treatment response. These components show non-random co-occurrence patterns suggesting functional integration. Implications: This framework suggests novel therapeutic strategies targeting system disintegration rather than cytotoxicity, potentially using approved reverse transcriptase inhibitors (e.g., Lamivudine) combined with targeted antibiotics and standard therapy. Keywords: HERVs, ecDNA, tumor microbiome, therapeutic resistance, cancer evolution, systems biology 1. Introduction 1.1 The Puzzle of Tumor "Intelligence" Despite six decades of intensive research, advanced cancer remains largely incurable. The dominant Somatic Mutation Theory (SMT) posits that cancer results from accumulated random mutations in oncogenes and tumor suppressors [1]. While this model explains cancer initiation, it fails to account for several puzzling phenomena in advanced disease: Parallel evolution at impossible speeds: The TRACERx consortium documented that patients receiving Osimertinib for lung cancer developed resistance within 3-6 weeks, with identical resistance mutations (C797S) appearing across anatomically distant metastases within the same timeframe [2,3]. The probability of identical mutations arising independently at multiple sites within weeks is exceedingly low (p < 10⁻⁸). This pattern has been observed repeatedly across multiple cancer types and therapeutic agents. Instantaneous genomic reorganization: Wu et al. (2023) demonstrated in a landmark Nature paper that extrachromosomal DNA (ecDNA) can restructure its composition within 48-72 hours under therapeutic pressure [4]. This speed of genomic adaptation far exceeds known random mutation rates by orders of magnitude, suggesting an active, directed process rather than passive selection. Directed metastasis: Cancer types show highly non-random metastatic preferences: colorectal cancer preferentially spreads to liver, prostate cancer to bone, and lung cancer to brain [5,6]. While Paget's "seed and soil" hypothesis (1889) partially explains this, the degree of specificity suggests active guidance mechanisms that remain poorly understood. These observations collectively suggest that advanced tumors possess emergent properties resembling coordinated biological systems rather than mere collections of independently mutating cells. 1.2 The Need for a New Framework We propose that the coordination observed in advanced tumors arises from the functional integration of three recently characterized tumor components: Human Endogenous Retroviruses (HERVs): Ancient viral sequences in our genome that reactivate under stress Extrachromosomal DNA (ecDNA): Circular DNA fragments that enable rapid genetic adaptation Tumor-associated microbiome: Bacteria living within tumors that influence tumor behavior This perspective is informed by: Complex systems theory: Emergent properties arise from component interactions [7] Symbiosis biology: Integrated multi-species systems can function as unified organisms [8] Recent molecular discoveries: Each component has been independently validated as functionally important in cancer 2. The Tripartite System: Components and Evidence 2.1 Human Endogenous Retroviruses (HERVs): The Communication Network 2.1.1 Biological Background Human Endogenous Retroviruses constitute approximately 8% of the human genome—more than the protein-coding genes themselves [9]. These sequences represent ancient retroviral infections that became integrated into the germline over millions of years of evolution. While most HERV sequences have accumulated mutations rendering them inactive, many retain functional elements including promoters, enhancers, and in some cases, intact open reading frames. Under normal conditions, HERVs are silenced through DNA methylation and histone modifications. However, cellular stress—including that induced by cancer and its treatment—can trigger demethylation and reactivation of these elements. 2.1.2 Evidence for HERV Activation in Cancer Multiple independent studies have demonstrated widespread HERV activation in malignancies: Panda et al. (2018) analyzed 31 cancer types from The Cancer Genome Atlas (TCGA), finding widespread HERV expression that correlated with immune infiltration patterns and clinical prognosis [10]. This comprehensive study established that HERV activation is not a rare event but a common feature of human cancers. Goering et al. (2015) reported that LINE-1, a type of retrotransposable element closely related to HERVs, is actively transcribed in 97% of colorectal cancers examined [11]. This near-universal activation suggests a fundamental role in colorectal carcinogenesis. Ishak et al. (2016) demonstrated that HERV-K activation in breast cancer correlates with aggressive phenotypes and poor outcomes [12]. Kassiotis and Stoye (2016) provided a comprehensive review establishing that HERV reactivation is a hallmark of cellular transformation [13]. 2.1.3 HERVs as an Intercellular Communication System The critical insight for our hypothesis is that HERVs are not merely activated—they can transmit information between cells: Sciamanna et al. (2019) demonstrated that LINE-1 elements produce RNA and proteins that are packaged into extracellular vesicles (EVs) and can be transferred to recipient cells [14]. This establishes a potential mechanism for HERV-mediated intercellular communication. Babaian and Mager (2023) reviewed evidence that HERVs produce envelope-like proteins capable of mediating cell-cell fusion and material transfer [15]. Chuong et al. (2017) showed that HERV sequences function as regulatory elements controlling gene networks through epigenetic mechanisms [16]. Importantly, these regulatory effects can be transmitted through extracellular vesicles. Conclusion: HERVs are not merely "junk DNA" but represent a latent communication infrastructure that becomes activated in cancer, potentially enabling coordination between distant tumor cells. 2.2 Extrachromosomal DNA (ecDNA): The Reprogrammable Memory 2.2.1 Biological Background Extrachromosomal DNA consists of circular DNA fragments that exist outside of chromosomes. First described in cancer cells by Cox et al. in 1965 [17], ecDNA was long considered a rare curiosity. Recent technological advances, particularly in whole-genome sequencing and cytogenetic analysis, have revealed that ecDNA is far more prevalent and important than previously recognized. Unlike chromosomal DNA, ecDNA: Lacks centromeres and segregates randomly during cell division Can rapidly change in copy number Often carries amplified oncogenes Shows different chromatin organization (more accessible) 2.2.2 Prevalence and Clinical Significance Recent large-scale studies have established ecDNA as a major factor in cancer: Turner et al. (2017) published a landmark Nature paper demonstrating that ecDNA is present in approximately 40% of advanced tumors across multiple cancer types [18]. This was far higher than previously estimated and established ecDNA as a common feature of aggressive cancers. Kim et al. (2020) confirmed ecDNA presence in ~14% of all cancers and ~30% of advanced/metastatic cancers, with strong association with poor prognosis [19]. Patients with ecDNA-positive tumors had significantly shorter survival. Verhaak et al. (2019) reviewed the evidence that ecDNA provides a major evolutionary advantage to cancer cells, enabling rapid adaptation [20]. 2.2.3 ecDNA as a Rapid Evolution Engine The most striking feature of ecDNA is its ability to enable ultra-fast genetic adaptation: Wu et al. (2023) made several remarkable discoveries published in Nature [4]: ecDNA can restructure its composition within 48-72 hours under selective pressure ecDNA is transferred between cells via cytoplasmic bridges Cells with ecDNA evolve approximately 100 times faster than cells without ecDNA enables rapid amplification of resistance genes under treatment Hung et al. (2021) demonstrated that ecDNA molecules form "transcriptional hubs" that can rapidly amplify oncogene expression and enable coordinated gene regulation [21]. Liang et al. (2023) showed that ecDNA functions as "mobile enhancers," able to reprogram gene expression patterns rapidly [22]. Conclusion: ecDNA represents a "reprogrammable genetic memory" that allows tumors to adapt to therapeutic pressure at speeds impossible for conventional chromosomal evolution. 2.3 Tumor-Associated Microbiome: The Environmental Sensors 2.3.1 From Skepticism to Acceptance For decades, tumors were assumed to be sterile. The discovery that bacteria routinely inhabit tumors has been one of the most surprising findings in recent cancer research. 2.3.2 Evidence for Intratumoral Bacteria Multiple high-impa